First Western Trust Bank Takes Position in Humana Inc. (NYSE:HUM)

First Western Trust Bank bought a new stake in Humana Inc. (NYSE:HUM) in the 4th quarter, HoldingsChannel.com reports. The firm bought 828 shares of the insurance provider’s stock, valued at approximately $379,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in HUM. E Fund Management Co. Ltd. purchased a new stake in shares of Humana in the fourth quarter valued at approximately $214,000. National Pension Service lifted its holdings in Humana by 3.0% during the fourth quarter. National Pension Service now owns 291,916 shares of the insurance provider’s stock valued at $133,642,000 after purchasing an additional 8,546 shares in the last quarter. Everpar Advisors LLC acquired a new stake in shares of Humana in the fourth quarter valued at about $645,000. Barlow Wealth Partners Inc. acquired a new position in shares of Humana during the 4th quarter worth about $1,977,000. Finally, Charles Schwab Investment Management Inc. lifted its stake in Humana by 3.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 818,040 shares of the insurance provider’s stock valued at $374,507,000 after buying an additional 26,879 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Humana Trading Up 3.3 %

Shares of NYSE HUM traded up $10.54 during trading on Thursday, reaching $334.68. The stock had a trading volume of 1,798,913 shares, compared to its average volume of 1,969,859. The business’s 50-day moving average price is $322.62 and its 200-day moving average price is $384.70. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $533.21. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67. The company has a market cap of $40.33 billion, a P/E ratio of 20.84, a PEG ratio of 1.86 and a beta of 0.50.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to the consensus estimate of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The firm’s revenue for the quarter was up 10.7% on a year-over-year basis. During the same period in the prior year, the firm earned $9.38 EPS. On average, equities research analysts predict that Humana Inc. will post 16.18 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.06%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s dividend payout ratio is presently 22.04%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on HUM shares. Cantor Fitzgerald reduced their target price on Humana from $391.00 to $360.00 and set a “neutral” rating for the company in a report on Thursday, April 25th. Truist Financial reaffirmed a “hold” rating and set a $550.00 target price on shares of Humana in a report on Friday, January 19th. UBS Group decreased their price target on shares of Humana from $334.00 to $326.00 and set a “neutral” rating on the stock in a research note on Thursday, April 25th. Stephens dropped their target price on Humana from $550.00 to $430.00 and set an “overweight” rating for the company in a report on Friday, January 26th. Finally, StockNews.com cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 26th. Eleven research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $424.50.

Insider Transactions at Humana

In related news, Director Jorge S. Mesquita acquired 545 shares of the business’s stock in a transaction on Tuesday, February 20th. The shares were bought at an average price of $367.09 per share, with a total value of $200,064.05. Following the completion of the acquisition, the director now owns 2,578 shares in the company, valued at $946,358.02. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.32% of the company’s stock.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.